Mimedx Group Inc (MDXG) Stock Price, Quote & News

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology

Sector: Healthcare

Phone: 770 651 9100

Website: www.mimedx.com

Address:

1775 West Oak Commons Court, NE, Marietta, United States

biomaster22 Dec. 28 at 6:37 PM

$MDXG is anyone besides me of this channel trade 6.25 to 7.50 is this all Mdxg is worth also when was the last insider buy ? Even the mgmt doesn’t believe

1 · Reply

RUDYRUDY Dec. 27 at 12:01 AM

$MDXG Much more to come with this story. Lobbyists and politicians in full force.

1 · Reply

Mobagri Dec. 26 at 6:40 PM

$MDXG happy for what? Dumb prediction.

2 · Reply

Mobagri Dec. 26 at 6:36 PM

$MDXG you have 300 products to compete with lower price of $127/cm . Significant revenue drop in 2026.

1 · Reply

GlobalInsights Dec. 26 at 5:28 PM

$MDXG Government f..ks MDXG again.

0 · Reply

Omstapocus Dec. 26 at 5:12 PM

$MDXG for all with their hair on fire, the only change that was made now requires everyone to apply for LCD certification eliminating the sixteen or so who were waiting for official approval. BUT…Since everyone now MUST submit their statistically and clinically significant data , having read all of the CMS releases of the past , there have only been the sixteen who have demonstrated actual efficacy. If the 300 products want to get reimbursed $127 having bilked the system $3000 , I say go for it but they’re going to have to show that it actually works. A press release from the company would be VERY helpful at this point. Their silence only fans the fire.

1 · Reply

theflynews Dec. 26 at 5:02 PM

Wound-care stocks slip after CMS reverses coverage decision - $MDXG - https://thefly.com/permalinks/entry.php/MDXGid4262002?1766768427C38

0 · Reply

Mobagri Dec. 26 at 2:26 PM

$MDXG with new CMS announcement, Epifix now has to compete with 300 similar products. Big cut in revenue.

1 · Reply

Omstapocus Dec. 25 at 1:57 PM

$MDXG I’m not sure that I am smart enough to determine what the CMS determination means functionally. As I read it , CMS will allow the local MACs to receive data for ALL requests for LCD approval and require published data and evidence for approval.So effectively they eliminated the carve out for the 16 +companies ( approved)and for MIMEDX means they have to start all over again. What I didn’t see is if companies can continue to be reimbursed for their products.I assume they can BUT the reimbursement rate will still be $127! I don’t think this will affect LCD approval for MImedx it just further delays the process dramatically and opens up the tent for approval for the 200 + companies that were previously eliminated. I think what’s different now is there are no approvals and all may apply. Hopefully MIMEDX will immediately send out a press release explaining how this affects the company. Never believed in SANTA anyway.Now have real world evidence that he definitely doesn’t exist.

1 · Reply

RUDYRUDY Dec. 25 at 6:26 AM

$MDXG Xmas present for mdxg shareholders? https://www.cms.gov/newsroom/fact-sheets/upcoming-update-final-local-coverage-determinations-lcds-certain-skin-substitutes

0 · Reply

MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel

Nov 13, 2025, 8:00 AM EST - 6 weeks ago

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

Nov 10, 2025, 4:01 PM EST - 6 weeks ago

MIMEDX to Participate in Upcoming Investor Conferences

Nov 4, 2025, 9:56 AM EST - 7 weeks ago

MiMedx: Breakout Setup Into A Policy Overhaul

Nov 3, 2025, 9:15 AM EST - 2 months ago

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

Oct 29, 2025, 6:56 PM EDT - 2 months ago

MiMedx Group, Inc. (MDXG) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:01 PM EDT - 2 months ago

MIMEDX Announces Record Revenue for Third Quarter 2025

Oct 15, 2025, 8:00 AM EDT - 2 months ago

MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

Oct 6, 2025, 9:28 AM EDT - 3 months ago

MIMEDX Announces Launch of EPIXPRESS®

Sep 3, 2025, 8:00 AM EDT - 4 months ago

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

Jul 30, 2025, 11:01 PM EDT - 5 months ago

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:01 PM EDT - 5 months ago

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

Jul 30, 2025, 8:00 AM EDT - 5 months ago

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

Jul 16, 2025, 8:00 AM EDT - 5 months ago

MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30

Jul 15, 2025, 9:15 AM EDT - 5 months ago

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

May 6, 2025, 8:00 AM EDT - 8 months ago

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

May 5, 2025, 8:30 AM EDT - 8 months ago

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

Apr 30, 2025, 9:52 PM EDT - 8 months ago

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:01 PM EDT - 8 months ago

MIMEDX Announces First Quarter 2025 Operating and Financial Results

Apr 10, 2025, 4:01 PM EDT - 9 months ago

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

Feb 27, 2025, 8:00 AM EST - 10 months ago

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

Feb 26, 2025, 10:50 PM EST - 10 months ago

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:01 PM EST - 10 months ago

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

Nov 14, 2024, 9:15 AM EST - 1 year ago

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

Oct 30, 2024, 9:38 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

Oct 14, 2024, 8:00 AM EDT - 1 year ago

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

Oct 8, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

Oct 1, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

Sep 11, 2024, 1:03 PM EDT - 1 year ago

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

Sep 4, 2024, 4:23 PM EDT - 1 year ago

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

Aug 26, 2024, 9:30 AM EDT - 1 year ago

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

Jul 31, 2024, 9:10 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:02 PM EDT - 1 year ago

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

Jul 31, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

Jul 22, 2024, 8:10 AM EDT - 1 year ago

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

Jun 26, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

Apr 30, 2024, 9:33 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces First Quarter 2024 Operating and Financial Results

Apr 16, 2024, 8:00 AM EDT - 1 year ago

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

Mar 20, 2024, 7:00 AM EDT - 1 year ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Feb 28, 2024, 8:46 PM EST - 1 year ago

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:01 PM EST - 1 year ago

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

Feb 20, 2024, 8:00 AM EST - 2 years ago

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

Feb 12, 2024, 8:00 AM EST - 2 years ago

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

Jan 22, 2024, 8:00 AM EST - 2 years ago

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

Jan 12, 2024, 4:00 PM EST - 2 years ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

Jan 11, 2024, 12:54 PM EST - 2 years ago

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

biomaster22 Dec. 28 at 6:37 PM

$MDXG is anyone besides me of this channel trade 6.25 to 7.50 is this all Mdxg is worth also when was the last insider buy ? Even the mgmt doesn’t believe

1 · Reply

RUDYRUDY Dec. 27 at 12:01 AM

$MDXG Much more to come with this story. Lobbyists and politicians in full force.

1 · Reply

Mobagri Dec. 26 at 6:40 PM

$MDXG happy for what? Dumb prediction.

2 · Reply

Mobagri Dec. 26 at 6:36 PM

$MDXG you have 300 products to compete with lower price of $127/cm . Significant revenue drop in 2026.

1 · Reply

GlobalInsights Dec. 26 at 5:28 PM

$MDXG Government f..ks MDXG again.

0 · Reply

Omstapocus Dec. 26 at 5:12 PM

1 · Reply

theflynews Dec. 26 at 5:02 PM

Wound-care stocks slip after CMS reverses coverage decision - $MDXG - https://thefly.com/permalinks/entry.php/MDXGid4262002?1766768427C38

0 · Reply

Mobagri Dec. 26 at 2:26 PM

$MDXG with new CMS announcement, Epifix now has to compete with 300 similar products. Big cut in revenue.

1 · Reply

Omstapocus Dec. 25 at 1:57 PM

1 · Reply

RUDYRUDY Dec. 25 at 6:26 AM

$MDXG Xmas present for mdxg shareholders? https://www.cms.gov/newsroom/fact-sheets/upcoming-update-final-local-coverage-determinations-lcds-certain-skin-substitutes

0 · Reply

WallStreetBuyDip Dec. 25 at 1:24 AM

Comparing trending tickers $MDXG vs $C: MDXG has risen slightly by 1.14% to $7.08 with a volume of 175.9K, which is below its average of 715.7K. In contrast, C has increased by 1.81% to $121.56 with a trading volume of 13.5M, just shy of its usual 14.8M. While both stocks are up, C shows a stronger upward movement in both price and volume compared to MDXG, which has not only a smaller price increase but also less trading activity than usual.

0 · Reply

mikesterz7 Dec. 25 at 12:22 AM

$MDXG PT 15

0 · Reply

Investnow54 Dec. 25 at 12:07 AM

$MDXG *******im telling you check out SQD if bored constant up for 2 days can buy on coinbase

0 · Reply

GlobalInsights Dec. 25 at 12:00 AM

$MDXG click on the http link at the bottom of the prior post. Says LCD coverage withdrawn for diabetic foot and leg ulcers?

0 · Reply

GlobalInsights Dec. 24 at 11:56 PM

$MDXG https://www.cms.gov/newsroom/fact-sheets/upcoming-update-final-local-coverage-determinations-lcds-certain-skin-substitutes

0 · Reply

DARKP00L Dec. 22 at 2:52 PM

$MDXG 09:45 on Dec. 22 2025 MiMedx Group Signs Agreement With Regen Lab USA For Distribution Of RegenKit-Wound Gel In U.S. #tradeideas

2 · Reply

Mobagri Dec. 19 at 6:52 PM

$MDXG https://www.marketbeat.com/instant-alerts/mimedx-group-nasdaqmdxg-price-target-lowered-to-1000-at-mizuho-2025-12-17/

1 · Reply

DARKP00L Dec. 19 at 2:05 PM

$MDXG 09:01 on Dec. 19 2025 MIMEDX Announces Publication In Journal Of Inflammation Focused On Immunomodulatory Effects Of Purion Processed Human Amniotic Membrane Allografts In Vitro #tradeideas

0 · Reply

anachartanalyst Dec. 17 at 5:02 PM

$MDXG https://anachart.com/wp-content/uploads/ana_temp/1765990904_soc-img.jpg

0 · Reply

Mobagri Dec. 17 at 3:24 PM

$MDXG There are 60 new products going through RCT. Relying on Epifix with Medicare cuts not good propects.

1 · Reply

JarvisFlow Dec. 17 at 3:05 PM

Mizuho has adjusted their stance on MiMedx Group ( $MDXG ), setting the rating to Outperform with a target price of 12 → 10.

0 · Reply

eeyore152 Dec. 15 at 10:19 PM

$MDXG https://www.cms.gov/newsroom/fact-sheets/upcoming-update-final-local-coverage-determinations-lcds-certain-skin-substitutes

1 · Reply

Market Cap	1.02B
Revenue (ttm)	348.88M
Net Income (ttm)	42.42M
EPS (ttm)	N/A
PE Ratio	18.63
Forward PE	19.40
Profit Margin	12.16%
Debt to Equity Ratio	0.01

Volume	1,688,500
Avg Vol	927,632
Day's Range	N/A - N/A
Shares Out	148.10M
Stochastic %K	23%
Beta	1.64
Analysts	Strong Sell
Price Target	$11.80